Results 201 to 210 of about 64,244 (297)
Very Long‐Term Stability of Tryptase in Frozen Serum Samples
Clinical &Experimental Allergy, Volume 55, Issue 3, Page 276-277, March 2025.
Florent Broussal +7 more
wiley +1 more source
Clinical characteristics and IgE-binding protein profiles of patients with buckwheat allergy in China. [PDF]
Bian S +5 more
europepmc +1 more source
ABSTRACT Objective To characterize paediatric hospitalizations for angioedema and identify the prevalence and outcomes of airway interventions using a large national database. Methods We performed a cross‐sectional analysis of the Kids' Inpatient Database (2003–2019), including paediatric patients (0–20 years) hospitalized with angioedema identified by
Saharsh Talwar +4 more
wiley +1 more source
The Gap Between Prescription and Practice: Adrenaline Autoinjector Carriage in an Australian Cohort
Clinical &Experimental Allergy, EarlyView.
Jason Chun Lao +6 more
wiley +1 more source
ABSTRACT The present guideline updates the initial ESCD patch testing guideline, summarizing all aspects of patch testing for the diagnosis of contact allergy in patients suspected of suffering, or having been suffering, from allergic contact dermatitis or other delayed‐type hypersensitivity skin and mucosal conditions. Sections with brief descriptions
Wolfgang Uter +23 more
wiley +1 more source
Clonal Mast Cell Disorders and Mutation Profile in Adults Initially Presenting with Mast Cell Activation (Anaphylaxis) versus Non-Anaphylactic Presentations: A Joint Allergy-Hematology Cohort. [PDF]
Pornsuthirat P +4 more
europepmc +1 more source
ABSTRACT Drug hypersensitivity reactions (DHRs) are common in children and are diagnostically challenging, with cutaneous manifestations being the most common presentation. Patch testing (PT) is a well‐established tool for investigating delayed T‐cell‐mediated reactions and is widely used in patients with contact dermatitis.
Gabriele Simonetti +7 more
wiley +1 more source
Editorial: Anaphylaxis challenges: idiopathic and rare causes. [PDF]
Al-Nesf MA +5 more
europepmc +1 more source

